ICT-enabled Social-emotional Learning: Development of Responsibility and Well-being in the Educational Environment (emoTIC)

April 29, 2026 updated by: Inmaculada Montoya Castilla, University of Valencia
The purpose of the study is to develop adolescents' social-emotional abilities to foster their personal and social responsibility, as well as their well-being, by means of a school-based intervention that addresses students, teachers and parents who participate in a social-emotional program using a technological platform. The program consists of activities based on solid theoretical frameworks on emotional intelligence, development of responsibility and meaningful learning.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

EmoTIC is an emotional education program focused on the development of social-emotional competences through an application that can be used in mobile devices and tablets.The program is based on a space adventure, and provides reinforcement through score points and more time for the additional games. The duration of the program is 8 weeks.

The emoTIC 8 version is designed so that teachers can easily carry it out in their classrooms. The application consists of application-guided activities that are put into practice in class, and includes other exercises that are meant to be carried out at home. The activities that are designed to be carried out during school hours are named "missions", and the exercises the students will do at home are called "trainings". Both are essential to adequately conduct the intervention.

The emoTIC SPACE version is designed so that it is carried out autonomously at home, through application-guided activities. This version includes 8 activities for each of the 4 areas.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
385

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
    • Valencia
      • Valencia, Valencia, Spain, 46010
        • Universitat de València

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

10 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • To have signed the informed consent (or their legal tutors).
  • Being between 11 and 18 years old.

Exclusion Criteria:

  • Inability to understand the activities or the language used.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Intervention group
During the tutoring time, the intervention program is carried out in the experimental group, through emoTIC. EmoTIC is an emotional education program focused on the development of social-emotional competences through an application that can be used in mobile devices and tablets.
Other: ICT-enabled Social-emotional Learning
ICT-enabled Social-emotional Learning
No Intervention: Control group
During the period in which the intervention program is conducted in the experimental group, the control group will remain in the waitlist (will not participate in the intervention), and will carry out the program once the study is finished.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Emotional Intelligence
Time Frame: Time 1 (first month)
Trait Meta-Mood Scale (TMMS-24)
Time 1 (first month)
Emotional Intelligence
Time Frame: Time 2 (4th month)
Trait Meta-Mood Scale (TMMS-24)
Time 2 (4th month)
Emotional Intelligence
Time Frame: Time 3 (up to 1 year)
Trait Meta-Mood Scale (TMMS-24)
Time 3 (up to 1 year)
Subjective Well-Being
Time Frame: Time 1 (first month)
Life satisfaction and positive and negative affects
Time 1 (first month)
Subjective Well-Being
Time Frame: Time 2 (4th month)
Life satisfaction and positive and negative affects
Time 2 (4th month)
Subjective Well-Being
Time Frame: Time 3 (up to 1 year)
Life satisfaction and positive and negative affects
Time 3 (up to 1 year)
Emotional Competence
Time Frame: Time 1 (first month)
Emotional Skills and Competence Questionnaire
Time 1 (first month)
Emotional Competence
Time Frame: Time 2 (4th month)
Emotional Skills and Competence Questionnaire
Time 2 (4th month)
Emotional Competence
Time Frame: Time 3 (up to 1 year)
Emotional Skills and Competence Questionnaire
Time 3 (up to 1 year)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Somatic complaints
Time Frame: Time 1 (first month)
The Somatic Complain List (SCL-10)
Time 1 (first month)
Somatic complaints
Time Frame: Time 2 (4th month)
The Somatic Complain List (SCL-10)
Time 2 (4th month)
Somatic complaints
Time Frame: Time 3 (up to 1 year)
The Somatic Complain List (SCL-10)
Time 3 (up to 1 year)
Depression, Anxiety and Stress
Time Frame: Time 1 (first month)
Depression, Anxiety and Stress Scale
Time 1 (first month)
Depression, Anxiety and Stress
Time Frame: Time 2 (4th month)
Depression, Anxiety and Stress Scale
Time 2 (4th month)
Depression, Anxiety and Stress
Time Frame: Time 3 (up to 1 year)
Depression, Anxiety and Stress Scale
Time 3 (up to 1 year)
Psychosocial adjustment
Time Frame: Time 1 (first month)
Strengths and Difficulties Questionnaire
Time 1 (first month)
Psychosocial adjustment
Time Frame: Time 2 (4th month)
Strengths and Difficulties Questionnaire
Time 2 (4th month)
Psychosocial adjustment
Time Frame: Time 3 (up to 1 year)
Strengths and Difficulties Questionnaire
Time 3 (up to 1 year)
Suicide ideation
Time Frame: Time 1 (first month)
"Sentia" Scale
Time 1 (first month)
Suicide ideation
Time Frame: Time 2 (4th month)
"Sentia" Scale
Time 2 (4th month)
Suicide ideation
Time Frame: Time 3 (up to 1 year)
"Sentia" Scale
Time 3 (up to 1 year)
Personality
Time Frame: Time 1 (first month)
Mini-Ipip Questionnaire
Time 1 (first month)
Personality
Time Frame: Time 2 (4th month)
Mini-Ipip Questionnaire
Time 2 (4th month)
Personality
Time Frame: Time 3 (up to 1 year)
Mini-Ipip Questionnaire
Time 3 (up to 1 year)
Self-esteem
Time Frame: Time 1 (first month)
Rosenberg Self-Esteem Scale
Time 1 (first month)
Self-esteem
Time Frame: Time 2 (4th month)
Rosenberg Self-Esteem Scale
Time 2 (4th month)
Self-esteem
Time Frame: Time 3 (up to 1 year)
Rosenberg Self-Esteem Scale
Time 3 (up to 1 year)
Self-Efficacy
Time Frame: Time 1 (first month)
General Self-Efficacy Scale
Time 1 (first month)
Self-Efficacy
Time Frame: Time 2 (4th month)
General Self-Efficacy Scale
Time 2 (4th month)
Self-Efficacy
Time Frame: Time 3 (up to 1 year)
General Self-Efficacy Scale
Time 3 (up to 1 year)
School Social Climate
Time Frame: Time 1 (first month)
Questionnaire to Assess School Social Climate (CECSCE)
Time 1 (first month)
School Social Climate
Time Frame: Time 2 (4th month)
Questionnaire to Assess School Social Climate (CECSCE)
Time 2 (4th month)
School Social Climate
Time Frame: Time 3 (up to 1 year)
Questionnaire to Assess School Social Climate (CECSCE)
Time 3 (up to 1 year)
Social Responsibility
Time Frame: Time 1 (first month)
Personal and Social Responsibility Questionnaire (PSRQ)
Time 1 (first month)
Social Responsibility
Time Frame: Time 2 (4th month)
Personal and Social Responsibility Questionnaire (PSRQ)
Time 2 (4th month)
Social Responsibility
Time Frame: Time 3 (up to 1 year)
Personal and Social Responsibility Questionnaire (PSRQ)
Time 3 (up to 1 year)
Subjective Happiness
Time Frame: Time 1 (first month)
Subjective Happiness Scale
Time 1 (first month)
Subjective Happiness
Time Frame: Time 2 (4th month)
Subjective Happiness Scale
Time 2 (4th month)
Subjective Happiness
Time Frame: Time 3 (up to 1 year)
Subjective Happiness Scale
Time 3 (up to 1 year)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Valencia

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Ministerio de Ciencia e Innovación, Spain

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Inmaculada Montoya-Castilla, PhD, Universitat de València

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 1, 2018

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 31, 2023

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 31, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
January 29, 2020

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 2, 2020

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 4, 2020

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 30, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 29, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • PSI2017-84005-R (Spanish Ministry of Science, Innovation and Universities)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adolescent - Emotional Problem

Clinical Trials on ICT-enabled Social-emotional Learning

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings